Tuesday, December 14, 2021 7:52:02 AM
There is certainly some truth to that and most traditional, conservative investors will probably heed this advice but there are also many new, younger investors with fewer resources and discretion who only care about getting in at or near the bottom and they can create a feeding frenzy that is not always based on fundamental investing principles or company history. There are many examples out there (GME, AMC…) and an entire segment of crypto that bears this out.
Frankly I’m surprised that the simple press release of the MacB partnership had such an impact on share price and I will be curious to see if it moves upward and is sustained for any length of time without revenue or a contract announcement. Not likely IMHO and will probably settle back in around a dime until then but I’m also more wrong than right these days when it comes to predicting the market.
Those sitting on the sidelines and waiting to get in at .50-1.00 may be SOL once this begins to run as it could jump to multiples of that overnight. We are all in it to win it and until then lets all have the best day, week, month, year…ever. Good luck to all!
Investors seek out balance and truth to help with their investment decisions, dubious hype (pro or con) in either direction does not fill the bill. Until then it’s One Day @ A Time.
Recent LQMT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 10:15:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2023 10:26:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:37:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 08:41:42 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM